Medtronic’s Strategic Investments in Diabetes Business: A More Precise and Patient-Centric Diabetes Care Solution Could Be Expected From the Three Recent Acquisitions.
In 2001, Medtronic strategically acquired Minimed and Medical Research Group to enter the battlefield of diabetes care management. During the last two years, mergers and acquisitions have also expanded its diabetes market. In 2018, Medtronic acquired Nutrino, a start-up company. It was aiming for Nutrino’s food database and the algorithm for predicting blood glucose after meals. Medtronic will integrate related technologies into its own diabetes products to help diabetes management. In 2019, Medtronic acquired Klue, a start-up company. Klue uses gesture sensing technology to monitor and record users’ eating behavior and give advice on eating behaviors/habits. Recently, Medtronic announced that it...View all